		Technical Data
O8065-05A	Osteoprotegerin, NT (OPG, Osteoclastogenesis Inhibitory Factor, OCIF)

Description:
Human OPG (Osteoprotegerin, also know as OCIF (Osteoclastogenesis inhibitory factor), is a member of the TNF receptor superfamily. Recombinant human OPG/OCIF specifically acts on bone tissues and increases bone mineral density and bone volume associated with a decrease of active osteoclast number.

Applications:
Suitable for use in ELISA, Western Blotting. Other applications not tested.

Recommended Dilution:
Western Blotting: 1:10,000
Optimal dilutions to be determined by the researcher.

Storage and Stability:
Lyophilized powder may be stored at 4°C for short-term only. Reconstitute to nominal volume by adding sterile 40-50% glycerol and store at -20°C. Reconstituted product is stable for 12 months at -20°C. For maximum recovery of product, centrifuge the original vial after thawing and prior to removing the cap. Further dilutions can be made in assay buffer.

Type	Isotype	Clone	Grade
Mab	IgG1	6D632	Affinity Purified

Size		Storage	Shipping	Source	Host
100ug		-20°C	Blue Ice	Human	Mouse

Concentration:

~1mg/ml

Immunogen:

Synthetic peptide corresponding to N-terminal aa 21-39 of human OPG (osteoprotegerin).

Purity:

Purified by Protein G affinity chromatography.

Form

Supplied as a lyophilized powder in PBS, pH 7.2. Reconstitute with 100ul of distilled water. Activity is not affected by slight turbidity. Clarify by centrifugation.

Specificity:

Recognizes human OPG.

Intended for research use only. Not for use in human, therapeutic, or diagnostic applications.